Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease

The potential therapeutic benefit of intravenous immunoglobulins (IVIGs) for acute attacks of myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is unknown. The objective was to describe the outcomes of IVIG treatment for acute MOGAD attacks. A retrospective observational study involving s...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Multiple sclerosis Ročník 29; číslo 9; s. 1080
Hlavní autori:	Lotan, Itay, Chen, John J, Hacohen, Yael, Abdel-Mannan, Omar, Mariotto, Sara, Huda, Saif, Gibbons, Emily, Wilf-Yarkoni, Adi, Hellmann, Mark A, Stiebel-Kalish, Hadas, Pittock, Sean J, Flanagan, Eoin P, Molazadeh, Negar, Anderson, Monique, Salky, Rebecca, Romanow, Gabriela, Schindler, Patrick, Duchow, Ankelien Solveig, Paul, Friedemann, Levy, Michael
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 01.08.2023
Predmet:	Autoantibodies Encephalomyelitis, Acute Disseminated - drug therapy Female Humans Immunoglobulins, Intravenous - therapeutic use Male Myelin-Oligodendrocyte Glycoprotein Myelitis, Transverse Neuromyelitis Optica Retrospective Studies effectiveness IVIG MOGAD outcomes safety acute treatment
ISSN:	1477-0970, 1477-0970
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!